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Abstract Human legumain was characterized following over-
expression in a murine cell line as the C-terminal Ig-fusion
protein. Upon acid treatment, the prolegumain autoproteolyzed
distal to two aspartic acid residues to yield a highly active form.
The ability of mature legumain to cleave after aspartic acid
residues was confirmed with a small peptide substrate. Substitu-
tion of alanine for the putative catalytic cysteine, or for either of
two strictly conserved histidine residues, partly or wholly
eliminated autoactivation but not the ability of wild-type
legumain to correctly process the variants to the properly sized
proteins.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Asparagine-speci¢c endoproteases (EC 3.4.22.34), a sub-
family of cysteine proteases with no homology to other
known proteases, are found in organisms as diverse as para-
sites, plants, and mammals [1^6]. They have been implicated
in processes such as degradation and processing of stored
plant vacuole proteins and blood £uke hemoglobin digestion.
For these reasons, they have commonly been called legumains
or hemoglobinases. We use the term legumain for the entire
family to di¡erentiate the schistosome homolog from digestive
parasite proteases of the cathepsin family. Legumains are syn-
thesized in prepro forms and are localized to intracellular
acidic vacuoles (plants) or to the gut (schistosomes). However,
little is known about the biochemistry of this family of pro-
teases. For instance, although N-terminal sequencing and the
size of the isolated native proteins indicate that maturation
involves cleavage of both N- and C-terminal regions, the na-
ture of this processing into active, mature forms is not well
understood. Furthermore, the low sequence similarity of these
proteins to other protease families has hampered the identi¢-
cation of the critical catalytic residues.
Here, we report the mouse preprolegumain sequence, and
describe the production of recombinant human prolegumain ^
the ¢rst e⁄cient production of a member of this protease
family. In addition, we examine its autocatalytic maturation.
This process reveals a previously unseen ability of this pro-
tease to cleave at aspartic acid as well as at asparagine resi-
dues.
2. Materials and methods
2.1. Protein expression and puri¢cation
Preprolegumain cDNA was identi¢ed as an EST from a human
dendritic cell cDNA library and isolated as the full-length clone.
PCR primers were designed to amplify the full preprolegumain coding
region from the cDNA incorporating a HindIII site in the 5P untrans-
lated region, and to add residues encoding PRPPTGN (an IgA pro-
tease cleavage site) followed by an XhoI site distal to Tyr433. The PCR
product was inserted into a modi¢ed form of pCDM8 (Invitrogen)
where the pCDM8 XhoI-NotI region was replaced with a fragment
encoding human immunoglobulin G1, Fc (residues 74^768 of acces-
sion number X70421) preceded by 5P-CTCGAGC-3P and £anked by
5P-GCGGCCGC-3P. The resulting expression plasmid was electropo-
rated into COP5 cells [7]. Cells from ¢ve electroporations were used to
seed 10-tray Cell Factories (Nunc). After 5^7 days in culture, the cells
had reached con£uence and the supernatant was harvested by ¢ltra-
tion. The 94 kDa IgG-fusion protein was puri¢ed by HiTrapA chro-
matography (Pharmacia), and eluted with 100 mM glycine-HCl, pH
3.0. Typical yields were 1 mg/l. Following storage at 4‡C for 48 h in
pH 3 bu¡er, the autoactivated protein was dialyzed into 100 mM
NaOAc, 100 mM NaCl, pH 5.0 and resubjected to HiTrapA chroma-
tography, with collection of the £owthrough fractions.
Prolegumain was prepared from the Ig-fusion protein after the ini-
tial HiTrapA column by treatment with a 1/50 (by weight) ratio of
IgA protease (Boehringer Mannheim) in PBS, 1 mM EDTA overnight
at 37‡C. Puri¢cation was e¡ected by negative HiTrapA chromatog-
raphy, with collection of the £owthrough.
2.2. Preparation of His47 Ala, Cys52Ala, and His150Ala variants
Mutagenic N-terminal and C-terminal PCR reactions were carried
out on the cDNA sequence using the 5P- and 3P-terminal primers in
conjunction with primers carrying the mutation. The two resulting
reaction products (for each variant) were used as template for syn-
thesis of the full-length product. Following con¢rmation of the muta-
tion by DNA sequencing the variant proteins were produced as for
wild-type.
2.3. Antibodies
Mouse monoclonal antibodies (mAb), which speci¢cally recognized
human legumain in Western blots, were generated by standard pro-
tocols from the Ig-fusion protein [8] using BALB/c mice (Simonsen).
Goat anti-human-IgG horseradish peroxidase was used to visualize
IgG bands.
2.4. Kinetic analysis
Fluorimetric determinations (SPEX Fluorolog) were calibrated us-
ing varying concentrations of AMC, for which a molar absorptivity of
18 000 at 354 nm was used. Concentrations of Z-AAN-AMC (1^100
WM, Enzyme Systems) were £uorimetrically standardized by complete
legumain cleavage to Z-AAN and AMC. Reactions were carried out
with 2.7 nM legumain in 100 mM sodium citrate, 50 mM NaCl, 10
mM DTT, 1% DMF, pH 6.0 at 25‡C. Kinetic constants were deter-
mined with the Eadie-Hofstee plot using Kaleidagraph software (Syn-
ergy Software).
Kinetic analysis of succ-YVAD-AMC (Bachem, 100 WM) was car-
ried out with 270 nM enzyme in 100 mM glycine-HCl, 10 mM DTT,
1% DMF, pH 3.0 at 25‡C, and compared with Z-AAN-AMC under
the same conditions.
3. Results
3.1. Overexpression of legumain
Human prolegumain fused to IgG was overexpressed in
transiently transfected mouse COP5 cells utilizing the native
secretion signal. A time course study showed that this material
¢rst appeared in the media 3 days post transfection, and that
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expression levels reached a plateau after approximately 5 days
(data not shown). No changes in the level of prolegumain-IgG
were seen with increased expression times, even though most
of the COP5 cells had died by the end of 7 days, indicating
that lysis of the cells led neither to an increase of legumain
concentration from release of intracellular material (indeed,
protein blots of cell pellets showed no evidence of intracellular
material), nor to a decrease due to degradation. Furthermore,
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Fig. 1. Alignment of mammalian legumains. The human sequence shows the entire IgG-fusion used for overexpression, where amino acids
1^435 and 436^676 represent the preprolegumain and IgG sequences respectively. The mouse sequence is that determined as the consensus se-
quence of ESTs, as described in the text. The partial pig sequence is from [6]. Identical residues are boxed and shaded, while similar residues
are boxed. The signal sequence comprises residues 1^17. t indicates observed autoactivation sites, 3 represents the predicted maturation sites,
and * shows possible N-glycosylated Asn residues.
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no anti-legumain or anti-IgG immunoreactive bands at lower
molecular weight were observed on protein blots. The prole-
gumain-IgG was puri¢ed from the supernatant by protein A
a⁄nity chromatography, eluting with pH 3 bu¡er. Initially,
we rapidly neutralized the eluted fractions and cleaved the
secreted fusion protein with IgA protease at an engineered
site lying in the linker between the legumain and the IgG
moieties. The resulting 56 kDa product was further puri¢ed
by negative protein A absorption to yield prolegumain. Treat-
ment of this material with N-glycosidase F resulted in a pro-
tein of approximately 40 kDa by Western blot (data not
shown), consistent with the size expected from the cDNA
sequence, which indicates that the di¡erence in size was due
to N-glycosylation at some or all of the four potential sites.
N-terminal amino acid sequence analysis con¢rmed that this
secreted product began at residue 18 of the open reading
frame (ORF), as predicted by PSORT [9] and Chen et al.
[6] (Fig. 1).
By analogy with other family members, maturation of hu-
man legumain is expected to require removal of both an
V11^14 residue N-terminal and a V145 residue C-terminal
prodomain. Therefore, treatment of both the IgG-fusion and
the Igase-cleaved material with a number of proteases was
explored in order to generate the active protein. Proteolysis
of the 94 kDa fusion protein with trypsin conjugated to agar-
ose beads at pH 8 resulted in a 34 kDa species that reacted
with the anti-legumain antibody with little or no further deg-
radation, consistent with the size expected for the mature,
glycosylated protein. Nevertheless, no proteolytic activity to-
ward any substrate could be detected with this preparation,
consistent with the reported instability of porcine legumain to
neutral or basic pH [6]. However, when the trypsin activation
was carried out at pH 5.5, the resultant 34 kDa protein had
limited proteolytic activity towards a large number of protein
substrates following extended incubations (data not shown).
By removal of the neutralization step following chromatog-
raphy, highly active human legumain could be prepared from
the prolegumain-IgG fusion protein: storage in pH 3 bu¡er at
4‡C for 2 days resulted in autoactivation (see below). The
mature protein was isolated by dialysis into pH 5 sodium
acetate bu¡er followed by negative protein A a⁄nity chroma-
tography. Both SDS-PAGE (Fig. 2) and gel ¢ltration chro-
matography (data not shown) indicated a molecular weight of
approximately 48 kDa.
3.2. Autoactivation of legumain
A⁄nity-puri¢ed prolegumain-IgG stored at pH 3 undergoes
autocatalytic activation. Autoactivation could not be e¡ected
by incubating unpuri¢ed prolegumain-IgG (i.e. the cell super-
natant) at pH 3, indicating that a⁄nity puri¢cation was nec-
essary for proteolysis to occur. No e¡orts were made to opti-
mize the activation conditions. Activation was followed both
by changes in the appearance of the material on SDS-PAGE
(Fig. 2), and by the increased catalytic activity towards Z-
AAN-AMC over time (data not shown). Bands on SDS-
PAGE were identi¢ed by Western blot versus both anti-IgG
and anti-legumain antibodies, and con¢rmed with amino acid
sequencing: the 94 kDa protein, which was recognized by
both antibodies, was cleaved to a 48 kDa band, reactive
only with anti-legumain, and a 36 kDa protein reactive only
with anti-IgG. Other low molecular weight protein bands did
not react with either antibody. Amino acid sequencing was
used to identify all the cleavage sites (Table 1), and revealed
that although the IgG chain was cleaved at at least two aspar-
agine residues, cleavage within the legumain chain occurred
only at aspartic acid residues.
3.3. Kinetic analysis
All members of the legumain protease family which have
been characterized have been found to be active only towards
N-terminally protected non-glycosylated asparagine-contain-
ing substrates. The recombinant human protein has maximal
activity at pH 6.1 (which was dependent on the bu¡er used),
with the kinetic constants kcat, 4 s31, Km, 20 WM, kcat/Km,
200 000 s31 M31, similar to the activities for other family
members [6,10]. We could detect no activity toward a gluta-
mine-containing substrate (Z-GAQ-AMC), con¢rming the
speci¢city of legumain towards asparagine, nor did we detect
any e¡ect of trypsin treatment on the size of the active mate-
rial or on its activity. The contrasting ability of trypsin to
generate a 34 kDa legumain product from prolegumain-IgG
versus its inability to cleave the 48 kDa autocatalytically proc-
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Fig. 2. Autoactivation and puri¢cation of legumain. Coomassie-
stained SDS-PAGE. Lane A: Legumain-Ig fusion protein, eluted
from a HiTrapA column; B: A, after storage at pH 3, 4‡C for
3 days; C: A, after storage at pH 3, 4‡C for 6 days. D: Puri¢ed
IgG. E: Second HiTrapA column load. F: HiTrapA £owthrough.
G: 2.5UColumn Wash. H: 2.5UEluate (Ig). M1 and M2 corre-
spond to Mark12 and SeeBlue (Qiagen) molecular weight markers
respectively.
Table 1
Autocleavage sites of prolegumain-Ig
Molecular weight (kDa) Sequence Identitya
55 P-X Unknownb
50c DPEDGGXH Legumain, aa 23^
36 LEPXSXDTH IgG, aa 442^
17 WEXET Unknownb
15 KALPAPXE IgG, aa 555^
14 KALPAPXE IgG, aa 555^
10 ARHLI Legumain, aa 343^
5^6 L/W-P/V-ETI Unknown
3 XENDEQD Unknown
Sequences are of bands shown in lane E, Fig. 2. Indicated sequences
are as determined by N-terminal sequencing of PVDF-immobilized
bands. The identities show the locations of the N-terminus of each
sequence. Those that are listed as unknown could not be matched.
aAmino acids refer to numbering of Fig. 1.
bThese bands are visible in recombinant expression of Ig alone, and
probably represent medium contaminants.
cThis sequence was determined from two di¡erent preparations, with
identical results.
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essed form likely indicates a conformational change in legu-
main upon maturation.
Consistent with the products observed during autoactiva-
tion, we found a low, but detectable, activity at pH 3 for an
aspartic acid-containing substrate: 100 WM succ-YVAD-AMC
was cleaved at a rate of 8 nmol/s by 270 nM enzyme while an
equimolar amount of Z-AAN-AMC was cleaved at a rate of
167 nmol/s under the same conditions. Although aspartic acid
cleavage is quite ine⁄cient, it is more than su⁄cient to ac-
count for the observed autoactivation. Activity toward succ-
YVAD-AMC was absent at the typical pH 6 assay conditions,
nor was it observed with the cell supernatant, or by puri¢ed,
activated protease exposed to neutral pH. Moreover, the ac-
tivity was fully inhibited by chicken egg white cystatin (data
not shown). These observations are consistent with the activ-
ity being entirely due to legumain.
3.4. His47 Ala, Cys52Ala, and His150Ala variants
Since the legumains display little similarity to other known
protease families, the active site residues have not been deter-
mined. From their patterns of inhibition [2,6], it is thought
that legumains are cysteine proteases. As Cys52 is the only
completely conserved cysteine within the mature sequence, it
is likely that this residue is the reactive nucleophile. In addi-
tion, cysteine proteases commonly contain a catalytically im-
portant histidine. Four histidine residues are completely con-
served within the legumain family and are therefore potential
catalytic residues: His47, His53, His150, and His268. We have
produced variant legumains with alanine substituted at posi-
tions 47 and 150 in order to test the roles of these residues,
and have also produced the Cys52Ala variant (Fig. 3). N-ter-
minal sequencing of all three variant fusion proteins gave the
sequence VPIDD indicating that the signal sequence of the
mutant proteins was correctly processed. Incubation of these
variants at pH 3 for extended periods of time resulted in little
or no change in size as determined by SDS-PAGE (Fig. 3),
consistent with reduced autocatalytic processing. Further-
more, although processing could be e¡ected for all three var-
iants to the properly sized material by the addition of a small
amount of wild-type protein (data not shown), no activity of
the mutants toward Z-AAN-AMC was observed.
3.5. Determination of mouse preprolegumain cDNA sequence
BLASTN searches of the dbEST database using the human
cDNA sequence as a probe revealed very high similarity to
overlapping mouse ESTs with the following accession num-
bers: AA000373, AA000961, AA107459, AA122993,
AA615503, AA688513, W11820, W14837, W35784, W35821,
W36795, W83121. A consensus compilation of these yielded a
putative full-length mouse cDNA sequence, with a corre-
sponding 83% amino acid identity to the human protein
(Fig. 1). Nucleotides following position 322 were con¢rmed
by sequencing IMAGE clone number 578262, corresponding
to the EST with accession number AA122993. This sequence
has been submitted to the GenBank database (accession num-
ber AF044266).
4. Discussion
In this paper, we describe the production of milligram
quantities of active human legumain in eukaryotic cell culture.
Since previous e¡orts to produce recombinant legumain fam-
ily members have met with limited success, this represents a
signi¢cant advance for this family of proteases. The activity of
the mature recombinant human legumain towards the tripep-
tide substrate Z-AAN-AMC was consistent with that of other
native family members. However, at low pH, activity towards
aspartic acid residues was also detected. As the pKa of an
isolated aspartic acid is approximately 4, we would expect
these residues to be largely protonated at pH 3, and therefore
functionally similar to asparagine. This similarity in structure
is likely responsible for the additional activity observed at low
pH.
We observed autoactivation of prolegumain-IgG following
a⁄nity puri¢cation and acidi¢cation. Several lines of evidence
point to these cleavage reactions being autocatalytic. First, we
see no processing with unpuri¢ed product, indicating that
impurities from the cell culture medium is unlikely to be re-
sponsible for this reaction. This observation further suggests
that an inhibitor must be removed preceding maturation and/
or that the reaction is intermolecular and only occurs when
the protein is concentrated on the a⁄nity resin. Second, mu-
tation of putative active site residues prevents autoprocessing
(partially or fully depending on the mutant), but still allows
processing by wild-type protein. Third, the sites of cleavage
observed are consistent with the speci¢city of legumain for
cleavage of peptide bonds following asparagine and aspartic
acid residues. This mechanism may be responsible for the
observation that acidi¢cation of native legumain during puri-
¢cation increased its activity 65% [10]. Autocatalytic activa-
tion following acidi¢cation of many proteases with low pH
optima has been reported [11^16]. Acid-pH triggered process-
ing may be a common mode for activation of lysosomal pro-
teases, by which they mature only when they reach the vesicles
in which they are to act, preventing inappropriate processing
within the cell. Interestingly, protonation of an aspartic acid
residue within a conserved motif is postulated to be a switch
in the autoactivation of papain by triggering a conformational
change in the proenzyme [17]. A similar motif is seen in many
of the cathepsins, indicating that they may also be regulated
in this manner. Furthermore, many of these proenzymes have
been shown to be stable at neutral pH ([18], for example), but
are deactivated rapidly when the mature enzyme is exposed to
neutral or basic pHs. This behavior is also seen for legumain.
The cleavage sites we observe are not the same as those
predicted to be the in vivo processing sites by alignment
with related legumains [6]. Nevertheless, the autoactivated
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Fig. 3. Legumain mutant proteins. Western blot of approximately
500 ng legumain. The predominant band in the mutant lanes is the
Ig-fusion following storage at pH 3, 4‡C for periods of time of at
least a month, whereas the major band for wild-type is the mature
protein. Lane M: molecular weight markers. A: Wild-type. B:
His47Ala. C: Cys52Ala. D: His150Ala.
S. Halfon et al./FEBS Letters 438 (1998) 114^118 117
material is nearly as active as the native porcine protein. This
may indicate that other proteases are partly or wholly respon-
sible for maturation of legumain in vivo, possibly by further
processing the autocatalytically cleaved material.
Legumain does not cleave any asparagine residues within its
own sequence, although it does cleave within the IgG portion
of the fusion protein: while there are several Asn residues
within legumain that are not part of glycosylation consensus
sequences, these appear to be unavailable to the enzyme active
site. The inability to cleave Asn residues within the legumain
sequence likely has a role in stabilizing the protease in vivo.
Non-reactivity of some Asn residues has been observed pre-
viously for other members of this family [6,19]. Additional
factors which determine why some asparagine residues and
not others are recognized are not currently understood since
no consensus sequence is apparent.
The broad distribution, acidic catalytic optimum, and insta-
bility of the mature protein to neutral pH is consistent with
legumain being localized to acidic intracellular compartments
such as lysosomes or endosomes. Targeting of soluble proteins
to these compartments is normally mediated by the mannose-
6-phosphate receptor following phosphorylation of carbohy-
drate chains. The fact that we could observe no intracellular
legumain in COP5 cells may be due to a number of factors.
First, the lysosomal sorting mechanism may simply be over-
whelmed by the overexpressed protein, or the phosphotrans-
ferase may be sterically blocked by the IgG moiety. In these
cases, the default pathway would be the secretory one. Sec-
ond, some transformed mouse cells have previously been
shown to have an altered lysosomal tra⁄cking pattern ([20],
and references therein), and COP5 cells may well have this
defect. Third, it is possible that legumain is normally secreted.
This would not rule out a lysosomal function if the propro-
tease is then endocytosed or pinocytosed.
In conclusion, we have produced active recombinant human
legumain. This system was used to study the autocatalytic
process and will be useful for more detailed investigation of
the structure-function properties of legumain. Although vari-
ous studies have shown that this cysteine endoprotease pref-
erentially cleaves following asparagine residues, it was found
to autocatalytically cleave only after aspartic residues, result-
ing in a highly active protease with the expected asparaginase
speci¢city.
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